Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Axogen Inc (NASDAQ: AXGN) was $18.62 for the day, down -3.47% from the previous closing price of $19.29. In other words, the price has decreased by -$3.47 from its previous closing price. On the day, 0.77 million shares were traded.
Ratios:
Our analysis of AXGN’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.91 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 577.40. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on July 01, 2024, initiated with a Outperform rating and assigned the stock a target price of $13.
Canaccord Genuity Upgraded its Hold to Buy on May 09, 2022, whereas the target price for the stock was revised from $10 to $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 ’25 when AMY MCBRIDE-WENDELL bought 5,000 shares for $20.01 per share.
Zaderej Karen L. bought 220,000 shares of AXGN for $4,050,000 on Jan 21 ’25. On Jan 14 ’25, another insider, Zaderej Karen L., who serves as the SENIOR ADVISOR of the company, bought 100,000 shares for $18.00 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.41 while its Price-to-Book (P/B) ratio in mrq is 7.91.
Stock Price History:
Over the past 52 weeks, AXGN has reached a high of $21.00, while it has fallen to a 52-week low of $5.55. The 50-Day Moving Average of the stock is 5.10%, while the 200-Day Moving Average is calculated to be 44.98%.
Shares Statistics:
A total of 44.15M shares are outstanding, with a floating share count of 41.88M. Insiders hold about 5.55% of the company’s shares, while institutions hold 81.57% stake in the company.
Earnings Estimates
Currently, 5.0 analysts are dedicated to thoroughly evaluating and rating the performance of Axogen Inc (AXGN) in the stock market.The consensus estimate for the next quarter is $0.08, with high estimates of $0.11 and low estimates of $0.06.
Analysts are recommending an EPS of between $0.45 and $0.19 for the fiscal current year, implying an average EPS of $0.28. EPS for the following year is $0.51, with 5.0 analysts recommending between $0.84 and $0.39.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 6 analysts. It ranges from a high estimate of $51.5M to a low estimate of $47.2M. As of the current estimate, Axogen Inc’s year-ago sales were $41.38MFor the next quarter, 6 analysts are estimating revenue of $53.44M. There is a high estimate of $54.1M for the next quarter, whereas the lowest estimate is $52.81M.
A total of 6 analysts have provided revenue estimates for AXGN’s current fiscal year. The highest revenue estimate was $218M, while the lowest revenue estimate was $216M, resulting in an average revenue estimate of $216.99M. In the same quarter a year ago, actual revenue was $187.34MBased on 6 analysts’ estimates, the company’s revenue will be $252.96M in the next fiscal year. The high estimate is $262.9M and the low estimate is $248M.
